Regulus Therapeutics Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
RGLS on Nasdaq
Location
4224 Campus Point Court, Suite 210, San Diego, California

Insiders trading volume in the past year

Regulus Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Stelios Papadopoulos Director $1.57 M May 20, 2024
Denis Drygin Chief Scientific Officer $119 K Mar 1, 2022
Joseph P. Hagan Chief Executive Officer, Director $68 K -$17.4 K -20.3% May 20, 2024
Christopher Aker Sr. VP & General Counsel $12 K -$6.51 K -35.2% May 20, 2024
Crispina Calsada Chief Financial Officer $6.88 K -$6.51 K -48.6% May 20, 2024
Simos Simeonidis Director Jun 9, 2022
Jason Raleigh Nunn Director May 20, 2024
Pascale Witz Director May 20, 2024
William H. Rastetter Director May 20, 2024
Preston Klassen President & Head of R & D, Director May 20, 2024
David Baltimore Director May 20, 2024
Kathryn J. Collier Director May 20, 2024
Alice Shih-hou Huang Director May 20, 2024
Hugh Rosen Director May 20, 2024

Recent Insider Transactions by Companies or Individuals for Regulus Therapeutics Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership